Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
Clinical trial NCT00038454 · SUSPENDED
Trial details
- NCT number
- NCT00038454
- Sponsor
- Hemosol
- Status
- SUSPENDED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.